Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties.

Patterson MS, Chance B, Wilson BC.

Appl Opt. 1989 Jun 15;28(12):2331-6. doi: 10.1364/AO.28.002331.

PMID:
20555520
2.

Phase contrast microscopy analysis of breast tissue: differences in benign vs. malignant epithelium and stroma.

Wells WA, Wang X, Daghlian CP, Paulsen KD, Pogue BW.

Anal Quant Cytol Histol. 2009 Aug;31(4):197-207.

3.

Preoperative therapy: what, when and for whom?

von Minckwitz G.

Ann Oncol. 2008 Jul;19 Suppl 5:v113-6. doi: 10.1093/annonc/mdn323. No abstract available.

PMID:
18611867
4.

Evaluation of biological pathways involved in chemotherapy response in breast cancer.

Tordai A, Wang J, Andre F, Liedtke C, Yan K, Sotiriou C, Hortobagyi GN, Symmans WF, Pusztai L.

Breast Cancer Res. 2008;10(2):R37. doi: 10.1186/bcr2088. Epub 2008 Apr 29.

5.

Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?

Esteva FJ, Hortobagyi GN.

J Natl Cancer Inst. 2008 Apr 16;100(8):521-3. doi: 10.1093/jnci/djn098. Epub 2008 Apr 8. No abstract available.

PMID:
18398093
6.

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN).

Chollet P, Abrial C, Durando X, Thivat E, Tacca O, Mouret-Reynier MA, Leheurteur M, Kwiatkowski F, Dauplat J, Penault-Llorca F.

Cancer J. 2008 Mar-Apr;14(2):128-32. doi: 10.1097/PPO.0b013e31816bdea2. Erratum in: Cancer J. 2014 Mar-Apr;20(2):166. Penault-Llorc, Frédérique [corrected to Penault-Llorca, Frédérique].

PMID:
18391619
7.

Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms.

Poplack SP, Tosteson TD, Wells WA, Pogue BW, Meaney PM, Hartov A, Kogel CA, Soho SK, Gibson JJ, Paulsen KD.

Radiology. 2007 May;243(2):350-9. Epub 2007 Mar 30.

PMID:
17400760
8.

Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy.

Cerussi A, Hsiang D, Shah N, Mehta R, Durkin A, Butler J, Tromberg BJ.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4014-9. Epub 2007 Feb 28.

9.

Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue.

Bartek M, Wang X, Wells W, Paulsen KD, Pogue BW.

J Biomed Opt. 2006 Nov-Dec;11(6):064007.

PMID:
17212530
10.

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L, Ricaud M, Bourbouloux E, Doutriaux I, Clouet M, Berton-Rigaud D, Bouriel C, Delecroix V, Garin E, Rouquette S, Resche I, Kerbrat P, Chatal JF, Campone M.

J Clin Oncol. 2006 Dec 1;24(34):5366-72. Epub 2006 Nov 6.

PMID:
17088570
11.

Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography.

Wang X, Pogue BW, Jiang S, Dehghani H, Song X, Srinivasan S, Brooksby BA, Paulsen KD, Kogel C, Poplack SP, Wells WA.

J Biomed Opt. 2006 Jul-Aug;11(4):041106.

PMID:
16965134
12.
13.

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy.

Manton DJ, Chaturvedi A, Hubbard A, Lind MJ, Lowry M, Maraveyas A, Pickles MD, Tozer DJ, Turnbull LW.

Br J Cancer. 2006 Feb 13;94(3):427-35. Erratum in: Br J Cancer. 2006 May 22;94(10):1544.

14.

Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.

Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R.

Breast Cancer Res. 2005;7(6):279-85. Epub 2005 Nov 28. Review.

15.

In vivo hemoglobin and water concentrations, oxygen saturation, and scattering estimates from near-infrared breast tomography using spectral reconstruction.

Srinivasan S, Pogue BW, Jiang S, Dehghani H, Kogel C, Soho S, Gibson JJ, Tosteson TD, Poplack SP, Paulsen KD.

Acad Radiol. 2006 Feb;13(2):195-202.

PMID:
16428055
16.

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM.

AJR Am J Roentgenol. 2005 Jun;184(6):1774-81.

PMID:
15908529
17.

Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.

Choe R, Corlu A, Lee K, Durduran T, Konecky SD, Grosicka-Koptyra M, Arridge SR, Czerniecki BJ, Fraker DL, DeMichele A, Chance B, Rosen MA, Yodh AG.

Med Phys. 2005 Apr;32(4):1128-39.

PMID:
15895597
18.

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.

Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW.

Breast Cancer Res Treat. 2005 May;91(1):1-10.

PMID:
15868426
19.

Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.

Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Lawton TJ, Barlow WE, Schubert EK, Mankoff DA.

Cancer. 2005 Feb 15;103(4):680-8.

20.

Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

Meisamy S, Bolan PJ, Baker EH, Bliss RL, Gulbahce E, Everson LI, Nelson MT, Emory TH, Tuttle TM, Yee D, Garwood M.

Radiology. 2004 Nov;233(2):424-31.

PMID:
15516615

Supplemental Content

Support Center